|
Pfizer Settles FCPA Charges; Settlement Lessened by Company’s Compliance Steps
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives